Startseite Newborn screening for inborn errors of metabolism in a northern Chinese population
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Newborn screening for inborn errors of metabolism in a northern Chinese population

  • Genxian Liu EMAIL logo , Xingying Liu und Yiming Lin EMAIL logo
Veröffentlicht/Copyright: 20. Januar 2023

Abstract

Objectives

Newborn screening (NBS) for inborn errors of metabolism (IEMs) has been successfully implemented in China. However, the data on the IEM profiles in many regions are lacking. This study aimed to report the incidence, disease spectrum, and genetic profile of IEMs in northern China.

Methods

A total of 36,590 newborns were screened using tandem mass spectrometry between January 2016 and April 2022. Newborns with positive results were referred for confirmatory testing.

Results

Ten patients were confirmed to have IEMs, with an overall incidence of 1:3,539 in the Rizhao region. Five types of IEMs were detected, including four patients with propionic acidemia (PA), three patients with methylmalonic acidemia (MMA), one of each with citrin deficiency, primary carnitine deficiency, and isobutyryl-CoA dehydrogenase deficiency. PA was the most common IEM, with an unexpectedly high incidence of 1:8,848, followed by MMA, with an incidence rate of 1:11,797. All patients had abnormal screening markers and harbored biallelic variants in their respective causative genes. Two novel PCCB variants (c.505G>A and c.1123_1124insG) were identified in patients with PA. In silico analyses predicted that these two variants were potentially pathogenic.

Conclusions

This study preliminarily clarified the incidence, disease spectrum, and genetic profile of IEMs in the Rizhao region. PA is the most common IEM and MMA is the second most common in our region. The two novel identified PCCB variants further expand the variant spectrum of PA. More attention should be paid to NBS, early diagnosis, and management of PA and MA.


Corresponding authors: Genxian Liu, Center of Medical Genetics, Rizhao Maternal and Child Health Care Hospital, 28 Weihai Road, 276800 Rizhao, Shandong Province, P.R. China, E-mail: ; and Yiming Lin, Center of Neonatal Disease Screening, Quanzhou Maternity and Children’s Hospital, 700 Fengze Street, 362000 Quanzhou, Fujian Province, P.R. China, E-mail:

Acknowledgments

We thank all the participants for their help and support. We would like to thank Editage (www.editage.cn) for English language editing.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Written informed consent was obtained from the parents of all the patients.

  5. Ethical approval: This study was approved by the Ethical Committee of Rizhao Maternity Hospital.

References

1. Lin, Y, Zheng, Q, Zheng, T, Zheng, Z, Lin, W, Fu, Q. Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population. Clin Chim Acta 2019;494:106–11. https://doi.org/10.1016/j.cca.2019.03.1622.Suche in Google Scholar PubMed

2. Mak, CM, Lee, HC, Chan, AY, Lam, CW. Inborn errors of metabolism and expanded newborn screening: review and update. Crit Rev Clin Lab Sci 2013;50:142–62. https://doi.org/10.3109/10408363.2013.847896.Suche in Google Scholar PubMed

3. Saudubray, JM, Garcia-Cazorla, A. Inborn errors of metabolism overview: pathophysiology, manifestations, evaluation, and management. Pediatr Clin North Am. 2018;65:179–208.10.1016/j.pcl.2017.11.002Suche in Google Scholar PubMed

4. Shi, XT, Cai, J, Wang, YY, Tu, WJ, Wang, WP, Gong, LM, et al.. Newborn screening for inborn errors of metabolism in mainland China: 30 years of experience. JIMD Rep 2012;6:79–83.10.1007/8904_2011_119Suche in Google Scholar PubMed PubMed Central

5. Lin, Y, Peng, W, Jiang, M, Lin, C, Lin, W, Zheng, Z, et al.. Clinical, biochemical and genetic analysis of Chinese patients with isobutyryl-CoA dehydrogenase deficiency. Clin Chim Acta 2018;487:133–8. https://doi.org/10.1016/j.cca.2018.09.033.Suche in Google Scholar PubMed

6. Lin, Y, Wang, W, Lin, C, Zheng, Z, Fu, Q, Peng, W, et al.. Biochemical and molecular features of Chinese patients with glutaric acidemia type 1 detected through newborn screening. Orphanet J Rare Dis 2021;16:339. https://doi.org/10.1186/s13023-021-01964-5.Suche in Google Scholar PubMed PubMed Central

7. Messina, M, Meli, C, Raudino, F, Pittala, A, Arena, A, Barone, R, et al.. Expanded newborn screening using tandem mass spectrometry: seven years of experience in eastern sicily. Int J Neonatal Screen 2018;4:12. https://doi.org/10.3390/ijns4020012.Suche in Google Scholar PubMed PubMed Central

8. Conejero, AC, Figueras, LM, Temprado, AO, Soto, PB, Rivada, AM, Perez, LP, et al.. Newborn screening program in the community of Madrid: evaluation of positive cases. Rev Esp Salud Publica 2020;94:e1–15.Suche in Google Scholar

9. Tang, C, Tan, M, Xie, T, Tang, F, Liu, S, Wei, Q, et al.. Screening for neonatal inherited metabolic disorders by tandem mass spectrometry in Guangzhou. Zhejiang Da Xue Xue Bao Yi Xue Ban 2021;50:463–71. https://doi.org/10.3724/zdxbyxb-2021-0260.Suche in Google Scholar PubMed PubMed Central

10. Yang, N, Gong, LF, Zhao, JQ, Yang, HH, Ma, ZJ, Liu, W, et al.. Inborn errors of metabolism detectable by tandem mass spectrometry in Beijing. J Pediatr Endocrinol Metab 2020;33:639–45. https://doi.org/10.1515/jpem-2019-0420.Suche in Google Scholar PubMed

11. Deng, K, Zhu, J, Yu, E, Xiang, L, Yuan, X, Yao, Y, et al.. Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: a census of over seven million newborns between 2016 and 2017. J Med Screen 2021;28:223–9. https://doi.org/10.1177/0969141320973690.Suche in Google Scholar PubMed

12. Tan, J, Chen, D, Chang, R, Pan, L, Yang, J, Yuan, D, et al.. Tandem mass spectrometry screening for inborn errors of metabolism in newborns and high-risk infants in southern China: disease spectrum and genetic characteristics in a Chinese population. Front Genet 2021;12:631688. https://doi.org/10.3389/fgene.2021.631688.Suche in Google Scholar PubMed PubMed Central

13. Yang, C, Zhou, C, Xu, P, Jin, X, Liu, W, Wang, W, et al.. Newborn screening and diagnosis of inborn errors of metabolism: a 5-year study in an eastern Chinese population. Clin Chim Acta 2020;502:133–8. https://doi.org/10.1016/j.cca.2019.12.022.Suche in Google Scholar PubMed

14. Yang, Y, Wang, L, Wang, B, Liu, S, Yu, B, Wang, T. Application of next-generation sequencing following tandem mass spectrometry to expand newborn screening for inborn errors of metabolism: a multicenter study. Front Genet 2019;10:86. https://doi.org/10.3389/fgene.2019.00086.Suche in Google Scholar PubMed PubMed Central

15. Zhang, R, Qiang, R, Song, C, Ma, X, Zhang, Y, Li, F, et al.. Spectrum analysis of inborn errors of metabolism for expanded newborn screening in a northwestern Chinese population. Sci Rep 2021;11:2699. https://doi.org/10.1038/s41598-021-81897-y.Suche in Google Scholar PubMed PubMed Central

16. Almasi, T, Guey, LT, Lukacs, C, Csetneki, K, Voko, Z, Zelei, T. Systematic literature review and meta-analysis on the epidemiology of propionic acidemia. Orphanet J Rare Dis 2019;14:40. https://doi.org/10.1186/s13023-018-0987-z.Suche in Google Scholar PubMed PubMed Central

17. Liu, Y, Chen, Z, Dong, H, Ding, Y, He, R, Kang, L, et al.. Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital. Orphanet J Rare Dis 2022;17:135. https://doi.org/10.1186/s13023-022-02271-3.Suche in Google Scholar PubMed PubMed Central

18. Hong, F, Huang, X, Zhang, Y, Yang, J, Tong, F, Mao, H, et al.. Screening for newborn organic aciduria in Zhejiang province:prevalence, outcome and follow-up. Zhejiang Da Xue Xue Bao Yi Xue Ban 2017;46:240–7.Suche in Google Scholar

19. Liu, Y, Liu, YP, Zhang, Y, Song, JQ, Zheng, H, Dong, H, et al.. Heterogeneous phenotypes, genotypes, treatment and prevention of 1 003 patients with methylmalonic acidemia in the mainland of China. Zhonghua Er Ke Za Zhi 2018;56:414–20.Suche in Google Scholar

20. Han, B, Cao, Z, Tian, L, Zou, H, Yang, L, Zhu, W, et al.. Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cblC type) in Shandong province, China. Brain Dev 2016;38:491–7. https://doi.org/10.1016/j.braindev.2015.10.016.Suche in Google Scholar PubMed

21. Kang, L, Liu, Y, Shen, M, Liu, Y, He, R, Song, J, et al.. A study on a cohort of 301 Chinese patients with isolated methylmalonic acidemia. J Inherit Metab Dis 2020;43:409–23. https://doi.org/10.1002/jimd.12183.Suche in Google Scholar PubMed

22. Zhou, W, Li, H, Wang, C, Wang, X, Gu, M. Newborn screening for methylmalonic acidemia in a Chinese population: molecular genetic confirmation and genotype phenotype correlations. Front Genet 2018;9:726. https://doi.org/10.3389/fgene.2018.00726.Suche in Google Scholar PubMed PubMed Central

23. Song, YZ, Zhang, ZH, Lin, WX, Zhao, XJ, Deng, M, Ma, YL, et al.. SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China. PLoS One 2013;8:e74544. https://doi.org/10.1371/journal.pone.0074544.Suche in Google Scholar PubMed PubMed Central

24. Lin, WX, Zeng, HS, Zhang, ZH, Mao, M, Zheng, QQ, Zhao, ST, et al.. Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution. Sci Rep 2016;6:29732. https://doi.org/10.1038/srep29732.Suche in Google Scholar PubMed PubMed Central

25. Lin, Y, Liu, Y, Zhu, L, Le, K, Shen, Y, Yang, C, et al.. Combining newborn metabolic and genetic screening for neonatal intrahepatic cholestasis caused by citrin deficiency. J Inherit Metab Dis 2020;43:467–77. https://doi.org/10.1002/jimd.12206.Suche in Google Scholar PubMed

26. Lin, Y, Zhang, W, Huang, C, Lin, C, Lin, W, Peng, W, et al.. Increased detection of primary carnitine deficiency through second-tier newborn genetic screening. Orphanet J Rare Dis 2021;16:149. https://doi.org/10.1186/s13023-021-01785-6.Suche in Google Scholar PubMed PubMed Central

27. Lin, Y, Lin, B, Chen, Y, Zheng, Z, Fu, Q, Lin, W, et al.. Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening. Orphanet J Rare Dis 2021;16:503. https://doi.org/10.1186/s13023-021-02126-3.Suche in Google Scholar PubMed PubMed Central

28. Sadat, R, Hall, PL, Wittenauer, AL, Vengoechea, ED, Park, K, Hagar, AF, et al.. Increased parental anxiety and a benign clinical course: infants identified with short-chain acyl-CoA dehydrogenase deficiency and isobutyryl-CoA dehydrogenase deficiency through newborn screening in Georgia. Mol Genet Metabol 2020;129:20–5. https://doi.org/10.1016/j.ymgme.2019.11.008.Suche in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2022-0543).


Received: 2022-10-23
Accepted: 2023-01-02
Published Online: 2023-01-20
Published in Print: 2023-03-28

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Thyroid – what is a healthy thyroid function test?
  4. Review
  5. Thyroid storm in pediatrics: a systematic review
  6. Opinion Paper
  7. DSD/intersex: historical context and current perspectives
  8. Original Articles
  9. Predictive value of 6 h postoperative parathyroid hormone level on permanent hypoparathyroidism in pediatric total thyroidectomy: a pilot study
  10. Evaluation of a nurse-led counselling intervention on selected outcome variables for parents of children with congenital adrenal hyperplasia
  11. The relationship between estrogen and subsequent growth restriction among adolescents with heavy menstrual bleeding at menarche
  12. An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
  13. Normal bone density but altered geometry in girls with Turner syndrome
  14. Newborn screening for inborn errors of metabolism in a northern Chinese population
  15. Evaluation of serum telomerase activity in normal-weight young girls with polycystic ovary syndrome and its relation to metabolic parameters
  16. Early onset of puberty during COVID-19 pandemic lockdown: experience from two Pediatric Endocrinology Italian Centers
  17. Using change in predicted adult height during GnRH agonist treatment for individualized treatment decisions in girls with central precocious puberty
  18. Short Communications
  19. Long-term experience with the use of a single histrelin implant beyond one year in patients with central precocious puberty
  20. Relationships among biochemical measures in children with diabetic ketoacidosis
  21. Case Reports
  22. Hyperthyroidism in McCune–Albright Syndrome – a case report
  23. Sexual precocity in the setting of parental use of a compounded testosterone cream: case report and review of the literature
  24. Intracardiac thrombosis following intravenous zoledronate treatment in a child with steroid-induced osteoporosis
  25. Identification of a novel mutation in the ALDOB gene in hereditary fructose intolerance
Heruntergeladen am 17.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0543/html
Button zum nach oben scrollen